Molecular mechanism and therapeutic modulation of high mobility group box 1 release and action: an updated review.
about
Linking Activation of Microglia and Peripheral Monocytic Cells to the Pathophysiology of Psychiatric DisordersConcepts and mechanisms underlying chemotherapy induced immunogenic cell death: impact on clinical studies and considerations for combined therapiesDAMPs from Cell Death to New LifeDoes Infection-Induced Immune Activation Contribute to Dementia?Novel Mechanisms of Herbal Therapies for Inhibiting HMGB1 Secretion or ActionMolecular isoforms of high-mobility group box 1 are mechanistic biomarkers for epilepsyEmerging role of HMGB1 in lung diseases: friend or foe.Blocking cold-inducible RNA-binding protein protects liver from ischemia-reperfusion injurymicroRNA-218 promotes gemcitabine sensitivity in human pancreatic cancer cells by regulating HMGB1 expressionAn ongoing search for potential targets and therapies for lethal sepsisSerum Amyloid A Stimulates PKR Expression and HMGB1 Release Possibly through TLR4/RAGE ReceptorsProbing the phenomenon of trained immunity in invertebrates during a transgenerational study, using brine shrimp Artemia as a model system.Blockade of Extracellular High-Mobility Group Box 1 Attenuates Systemic Inflammation and Coagulation Abnormalities in Rats with Acute Traumatic Coagulopathy.HMGB1 release by H2O2-induced hepatocytes is regulated through calcium overload and 58-F interference.Role of Microglial Activation in the Pathophysiology of Bacterial Meningitis.The self-association of HMGB1 and its possible role in the binding to DNA and cell membrane receptors.Levobupivacaine attenuates lipopolysaccharide-induced acute lung injury.Toll-like receptor 9 enhances bacterial clearance and limits lung consolidation in murine pneumonia caused by methicillin resistant Staphylococcus aureusHMGB1-TLR4-IL23-IL17A axis promotes paraquat-induced acute lung injury by mediating neutrophil infiltration in mice.Pulmonary Epithelial TLR4 Activation Leads to Lung Injury in Neonatal Necrotizing Enterocolitis.Ulinastatin post-treatment attenuates lipopolysaccharide-induced acute lung injury in rats and human alveolar epithelial cellsNMI and IFP35 serve as proinflammatory DAMPs during cellular infection and injury.Dengue fatal cases present virus-specific HMGB1 response in peripheral organs.Sequestering of damage-associated molecular patterns (DAMPs): a possible mechanism affecting the immune-stimulating properties of aluminium adjuvants.Propofol Protects Rats and Human Alveolar Epithelial Cells Against Lipopolysaccharide-Induced Acute Lung Injury via Inhibiting HMGB1 Expression.Danger signals: Chemotherapy enhancers?MicroRNA-142-3p Inhibits Chondrocyte Apoptosis and Inflammation in Osteoarthritis by Targeting HMGB1.HMGB1/TLR4 signaling induces an inflammatory response following high-pressure renal pelvic perfusion in a porcine model.HMGB1 promotes ductular reaction and tumorigenesis in autophagy-deficient livers.Ischemic preconditioning attenuates acute lung injury after partial liver transplantation.Cell permeable HMGB1-binding heptamer peptide ameliorates neurovascular complications associated with thrombolytic therapy in rats with transient ischemic stroke
P2860
Q26745417-6512CFD9-41BC-4147-B7D3-5A2BABD5ED6FQ26781215-55A08379-0F1B-49E8-A31A-050B88F2946CQ26782785-59DE59B1-6A31-49F3-BE0F-E7DDB4417B24Q26783354-84628AE7-F939-465E-892C-BB1318EEA202Q27009468-B2072713-CB32-4AB9-91DD-EA49165DA903Q30854108-12938ACA-9E79-4CD6-A2FD-E2479350A653Q33684145-0F9B2571-5561-4724-A7E8-FB06EA877CF5Q34735198-6810AA64-B78E-4F47-8513-C9DA08307B87Q35812824-32EDB975-EDD7-426A-940C-5906392C60FBQ35930160-D54F072D-AB0E-444A-A3FA-E54118FAAF52Q36167046-3A1C36D6-9B64-4490-90F4-95751897770AQ36579402-06F60EC1-4C8A-4071-8BDD-BBB5BB8EDF77Q37135898-937F2EDE-D729-4E14-B31C-58D9694129F4Q37742967-46327B04-F613-4E0E-AB53-AD876EF27752Q38368299-99C94B58-1BEB-425C-903D-CABF650F2FECQ38777560-0416FAC6-5951-4933-BF88-1B036FBA9ACBQ39909288-9CBED719-3C3D-4013-A831-39FB2EE5CB01Q40581507-F1E25888-8C5D-4751-B22E-A45AEB2F2F18Q42035297-DA1F5A03-147C-4929-9223-2C92F447F49CQ42166575-E71C8B08-0FCA-4F0D-80A4-ABF2C350DD96Q42315219-407DAC9E-EB78-4A0F-A533-333A5D269BF4Q42379020-44C0BBD6-81BD-452D-B158-5576BFFE48B1Q45324373-9E2452CB-7CAC-4ABF-B3DD-D505BAC1C32DQ47123344-7731E5B0-EE61-49B9-BD15-1FC4F49766F6Q47580660-93FC7F4B-9FEC-4A29-9D57-18592314FB7DQ47659090-88474957-C42C-4900-AC72-6E4DE63511E5Q48146266-F036BDF8-D4DE-461F-8F59-15300AD9B7AAQ51673193-90BF7CC4-A3D4-45A4-A0D3-9F2FF4845BB1Q52646732-1B561A40-D28C-40AD-B425-9EA6CB51902BQ55039365-489C8BFB-49B6-44D2-BDFE-EB6661A55B46Q58713675-4C57CEEE-A761-4684-B7A6-8244BE8C43E1
P2860
Molecular mechanism and therapeutic modulation of high mobility group box 1 release and action: an updated review.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Molecular mechanism and therap ...... and action: an updated review.
@ast
Molecular mechanism and therap ...... and action: an updated review.
@en
type
label
Molecular mechanism and therap ...... and action: an updated review.
@ast
Molecular mechanism and therap ...... and action: an updated review.
@en
prefLabel
Molecular mechanism and therap ...... and action: an updated review.
@ast
Molecular mechanism and therap ...... and action: an updated review.
@en
P2093
P2860
P1476
Molecular mechanism and therap ...... and action: an updated review.
@en
P2093
P2860
P304
P356
10.1586/1744666X.2014.909730
P577
2014-04-19T00:00:00Z